STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

The FDA has laid out a plan resembling the annual flu vaccine campaign, and the FDA's committee voted on one part of it. Here's what we know.

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

The Vaccines and Related Biological Products Advisory Committee meets Thursday to consider how to update guidelines for COVID ...

A federal advisory panel Thursday discussed ways to simplify and routinize COVID-19 vaccines more than two years after the ...

The CDC and FDA announced ... the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over, but said they were continuing to recommend the shots. The surveillance ...

The U.S. Food and Drug Administration vaccine advisory panel on Thursday voted unanimously to recommend that the agency phase ...

Once adopted by the FDA and Centers for Disease Control and Prevention, the change would effectively end use of the original "monovalent" shots that were developed initially in the pandemic, aimed at ...

The Food and Drug Administration's proposal was outlined in its briefing documents ahead of a meeting of its panel of ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...